Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
Veerle Noë(Ghent University Hospital), Marc Mareel(Ghent University Hospital), Howard C. Crawford(Henry Ford Health System), Barbara Fingleton(Vanderbilt University), Wim F. A. Steelant(St. Thomas University), Stefan Vermeulen(Ghent University Hospital), Erik Bruyneel(Ghent University Hospital), Lynn M. Matrisian(Pancreatic Cancer Action Network), Kathleen Jacobs(Ghent University Hospital)
Cited by 688
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The matrix‐degrading metalloproteinases
|BioEssays|1992|1.4k